MedTrace Logo

CIMT and BIMT Affect Functional Outcome in CP

NCT04211623 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2019-12-26

No results posted yet for this study

Summary

The aim of this randomized controlled trial is to determine the effects of constraint induced movement therapy CIMT and BIM bimanual activities on functional outcome in hemiplegic CP. Two randomized groups of patients with CP are treated with constrained arm for three hours on affected side and bimanual activities on BIM group respectively. Both, male and female patients meeting the inclusion criteria will be included. Patients having concurrent malignancy, infection, trauma or any bony deformity will be excluded.

Conditions

  • Cerebral Palsy, Congenital

Interventions

OTHER

Constraint induced movement therapy

Constrained on more affected side for three hours. To minimize the learned non use in hemiplegic CIMT is applied and criteria of applying CIMT is; * 10 degrees active wrist extension on the affected hand, * 10 degrees active thumb abduction, * 10 º active extension of any two digits on the side or hand which is limited due to damage. In order to gain the maximum good results from CIMT technique following points should also be considered attentively. Affected arm should move to 45 degrees shoulder flexion and abduction, and 90 degrees of elbow flexion and extension. Constrained with cotton sling. 3 to 5 upper limb functional activities like * using fork or a spoon, * combing hair * brushing teeth * writing * dressing all activities are performed for 10 t0 15 minutes in period of three hours on alternate days in a week

OTHER

Bimanual activities

Bimanual activities of both hands are performed like Set of bimanual activities is used to assess the bimanual hand function. Five bimanual activities are performed such as * carrying a tray, * cutting a fruit with a knife, * holding and cutting the paper with scissor, * buttoning and * Carrying heavy objects with both hands. Every activity was performed for 10 t0 15 minutes on alternate days for a period of 6 weeks session.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Mir Arif Hussain, PhD* · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2019-06-30
Completion
2019-07-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04211623 on ClinicalTrials.gov